Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1766-1776
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1766
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1766
Table 3 Survival rates of different follow-up durations between non-peripartum primary liver cancer and peripartum primary liver cancer patients
| Follow-up duration | Survival rate (%) | P value | |
| Non-peripartum primary liver cancer | Peripartum primary liver cancer | ||
| ≤ 0.5 | 78.94 | 71.79 | 0.254 |
| ≤ 1 | 63.61 | 60.84 | 0.611 |
| ≤ 3 | 44.85 | 30.42 | 0.111 |
| ≤ 5 | 39.59 | 27.38 | 0.117 |
- Citation: Tseng GW, Lin MC, Lai SW, Peng CY, Chuang PH, Su WP, Kao JT, Lai HC. Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan. World J Hepatol 2021; 13(11): 1766-1776
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1766.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1766